Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.
3.

Predicting drug efficacy for cognitive deficits in schizophrenia.

Hagan JJ, Jones DN.

Schizophr Bull. 2005 Oct;31(4):830-53. Review.

PMID:
16177277
4.

Developing drugs for cognitive impairment in schizophrenia.

Breier A.

Schizophr Bull. 2005 Oct;31(4):816-22. Review.

PMID:
16150959
5.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
6.
7.

Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.

Barak S, Weiner I.

Pharmacol Biochem Behav. 2011 Aug;99(2):164-89. doi: 10.1016/j.pbb.2011.03.011. Review.

PMID:
21420999
8.
9.

Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.

Sumiyoshi T, Bubenikova-Valesova V, Horacek J, Bert B.

Adv Ther. 2008 Oct;25(10):1037-56. doi: 10.1007/s12325-008-0102-2. Review.

PMID:
18839076
10.

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR.

Biol Psychiatry. 2004 Sep 1;56(5):301-7. Review.

PMID:
15336511
11.

Animal models of cognitive function.

Decker MW.

Crit Rev Neurobiol. 1995;9(4):321-43. Review.

PMID:
8829849
12.

Preclinical research into cognition enhancers.

Sarter M.

Trends Pharmacol Sci. 2006 Nov;27(11):602-8. Review.

PMID:
16997388
13.
14.
15.

Animal models of schizophrenia.

Young JW, Zhou X, Geyer MA.

Curr Top Behav Neurosci. 2010;4:391-433. Review.

PMID:
21312408
16.

Cognitive deficits in patients with schizophrenia: effects and treatment.

Keefe RS.

J Clin Psychiatry. 2007;68 Suppl 14:8-13. Review.

17.

Neurocognitive rehabilitation for schizophrenia.

Kurtz MM.

Curr Psychiatry Rep. 2003 Aug;5(4):303-10. Review.

PMID:
12857534
18.

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.

Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP.

J Clin Psychiatry. 2009 Jan;70(1):104-12. Review.

PMID:
19026265
19.

Treatment of cognitive deficits in schizophrenia.

Bowie CR, Harvey PD.

Curr Opin Investig Drugs. 2006 Jul;7(7):608-13. Review.

PMID:
16869112
20.

Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.

Korff S, Harvey BH.

Psychiatr Clin North Am. 2006 Jun;29(2):371-90. Review.

PMID:
16650714
Items per page

Supplemental Content

Support Center